OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting SARS-CoV-2 papain-like protease in the postvaccine era
Anh‐Tien Ton, Mohit Pandey, Jason R. Smith, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 906-919
Open Access | Times Cited: 38
Anh‐Tien Ton, Mohit Pandey, Jason R. Smith, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 906-919
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Mutational Profiling of SARS-CoV-2 PLpro in human cells reveals requirements for function, structure, and drug escape
Xinyu Wu, Margareta Go, Julie V. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Xinyu Wu, Margareta Go, Julie V. Nguyen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors
Suman Khan, Efrat Ozer Partuk, Jeanne Chiaravalli, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110019-110019
Open Access
Suman Khan, Efrat Ozer Partuk, Jeanne Chiaravalli, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 110019-110019
Open Access
Computational Modeling and Inhibition of SARS-COV-2 Papain-like Protease Enzyme: A Potential Therapeutic Approach for COVID-19
Auwal Rabiu Auwal, Isa Abdullahi Baba, Evren Hınçal, et al.
Journal of Biosafety and Biosecurity (2024) Vol. 6, Iss. 3, pp. 211-221
Open Access
Auwal Rabiu Auwal, Isa Abdullahi Baba, Evren Hınçal, et al.
Journal of Biosafety and Biosecurity (2024) Vol. 6, Iss. 3, pp. 211-221
Open Access
In-cell bioluminescence resonance energy transfer (BRET)-based assay uncovers ceritinib and CA-074 as SARS-CoV-2 papain-like protease inhibitors
Mei Li, Zhuchun Bei, Yongtian Yuan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Mei Li, Zhuchun Bei, Yongtian Yuan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Computational Drug Design Strategies for Fighting the COVID-19 Pandemic
Mohammed Hakmi, El Mehdi Bouricha, Abdellatif Soussi, et al.
Advances in experimental medicine and biology (2024), pp. 199-214
Closed Access
Mohammed Hakmi, El Mehdi Bouricha, Abdellatif Soussi, et al.
Advances in experimental medicine and biology (2024), pp. 199-214
Closed Access
Thiol-Reactive or Redox-Active: Revising a Repurposing Screen Led to a New Invalidation Pipeline and Identified a True Noncovalent Inhibitor Against Papain-like Protease from SARS-CoV-2
Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 66-77
Open Access
Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 1, pp. 66-77
Open Access
Integration of Computational and Experimental Techniques for the Discovery of SARS-CoV-2 PLpro Covalent Inhibitors
Ho Ying Huang, Sharon Pinus, Xiao Cong Zhang, et al.
(2023)
Open Access | Times Cited: 1
Ho Ying Huang, Sharon Pinus, Xiao Cong Zhang, et al.
(2023)
Open Access | Times Cited: 1
Mass spectrometric assays monitoring the deubiquitinase activity of the SARS-CoV-2 papain-like protease inform on the basis of substrate selectivity and have utility for substrate identification
Lennart Brewitz, H. T. Henry Chan, Petra Lukacik, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117498-117498
Open Access | Times Cited: 1
Lennart Brewitz, H. T. Henry Chan, Petra Lukacik, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117498-117498
Open Access | Times Cited: 1
Resolving the pharmacological redox-sensitivity of SARS-CoV-2 PLpro in drug repurposing screening enabled identification of the competitive GRL-0617 binding site inhibitor CPI-169
Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Maria Kuzikov, Stefano Morasso, Jeanette Reinshagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Natural phytoconstituents and herbal supplements: A potential therapeutic strategies against COVID infection
Ganesh Jayram Lamkhade, Pratik Dilip Deshmukh, Suvir Ramesh Darekar, et al.
World Journal of Biology Pharmacy and Health Sciences (2023) Vol. 13, Iss. 1, pp. 028-038
Open Access
Ganesh Jayram Lamkhade, Pratik Dilip Deshmukh, Suvir Ramesh Darekar, et al.
World Journal of Biology Pharmacy and Health Sciences (2023) Vol. 13, Iss. 1, pp. 028-038
Open Access
The Role of Structural Biology Task Force: Validation of the Binding Mode of Repurposed Drugs Against SARS-CoV-2 Protein Targets
Stefano Morasso, Elisa Costanzi, Nicola Demitri, et al.
SpringerBriefs in applied sciences and technology (2023), pp. 51-59
Closed Access
Stefano Morasso, Elisa Costanzi, Nicola Demitri, et al.
SpringerBriefs in applied sciences and technology (2023), pp. 51-59
Closed Access
High throughput screening identifies broad-spectrum Coronavirus entry inhibitors
Suman Khan, Efrat Ozer Partuk, Jeanne Chiaravalli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Suman Khan, Efrat Ozer Partuk, Jeanne Chiaravalli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
For novel cardiovascular therapy discovery and development
Jerry C. Madukwe
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 885-887
Closed Access
Jerry C. Madukwe
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 885-887
Closed Access
